|
Volumn 21, Issue 3, 2010, Pages 454-459
|
The role of oral L-carnitine therapy in chronic hemodialysis patients.
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIANEMIC AGENT;
CARNITINE;
ERYTHROPOIETIN;
HEMOGLOBIN;
ADULT;
ANEMIA;
ARTICLE;
BLOOD;
CHRONIC DISEASE;
DIET SUPPLEMENTATION;
DRUG EFFECT;
ECHOCARDIOGRAPHY;
EGYPT;
FEMALE;
HEART VENTRICLE FUNCTION;
HUMAN;
KIDNEY DISEASE;
MALE;
METABOLISM;
MIDDLE AGED;
ORAL DRUG ADMINISTRATION;
PATHOPHYSIOLOGY;
RENAL REPLACEMENT THERAPY;
TIME;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ADULT;
ANEMIA;
CARNITINE;
CHRONIC DISEASE;
DIETARY SUPPLEMENTS;
ECHOCARDIOGRAPHY;
EGYPT;
ERYTHROPOIETIN;
FEMALE;
HEMATINICS;
HEMOGLOBINS;
HUMANS;
KIDNEY DISEASES;
MALE;
MIDDLE AGED;
RENAL DIALYSIS;
TIME FACTORS;
TREATMENT OUTCOME;
VENTRICULAR FUNCTION;
YOUNG ADULT;
|
EID: 77955504503
PISSN: 13192442
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (15)
|
References (0)
|